Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.

@article{Silbermann2018UsingTA,
  title={Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.},
  author={Elizabeth Silbermann and Lindsey Wooliscroft and Dennis N. Bourdette},
  journal={Current neurology and neuroscience reports},
  year={2018},
  volume={18 8},
  pages={
          49
        }
}
PURPOSE OF REVIEW Clinical trials using agents directed at neuroprotection and remyelination in multiple sclerosis (MS) are needed. As optic neuritis (ON) is common in people with MS and the pathology of ON is similar to other MS lesions in the brain, measurements of the anterior visual system are frequently utilized in neuroprotection and remyelination… CONTINUE READING